Fulcrum Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Fulcrum Asset Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.63K	Buy	+138	New	+$7.09K	﹤0.01%	725

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fulcrum Asset Management's PBH Position: Q2 2026 in Review

Fulcrum Asset Management opened a new position in Prestige Consumer Healthcare (PBH) in Q2 2026: 138 shares worth $6.63K. The stake represents ﹤0.01% of the portfolio and ranks #725 among its holdings.

318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

Fulcrum Asset Management held 138 shares of Prestige Consumer Healthcare worth $6.63K as of Q2 2026.
Prestige Consumer Healthcare was a new Fulcrum Asset Management position in Q2 2026.
Prestige Consumer Healthcare made up ﹤0.01% of Fulcrum Asset Management's portfolio in Q2 2026, its #725 holding.
318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.